AXSM

Axsome Therapeutics Inc (AXSM)

US
$ 132.24.03%

Price Chart

Key Statistics

Market Cap
$ 5.2B
P/E Ratio
0.00
Revenue (TTM)
$ 432.16M
Volume
1.63M
52W High
$ 139.13
52W Low
$ 64.11
Dividend Yield
0.00%
Beta
0.45

Technicals

50-Day MA
112.7607
200-Day MA
99.9679
52 Week High
139.1299
52 Week Low
64.11

About AXSM

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Employees
712
Headquarters
New York, NY
CEO
Dr. Herriot Tabuteau M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg